TERC telomerase subunit gene copy number in different disease stages of non-Hodgkin lymphoma and in hepatitis C

Cancer Investigation

Volumn 28, Issue 2, 2010, Pages 181-185

  Goldberg Bittman, L ^a,b   Kitay Cohen, Y ^a,c   Fejgin, M D ^a,c   Hadary, R ^a,c   Quitt, M ^d   Amiel, A ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d Carmel Hospital   (Israel)

Author keywords

Fish; Hepatitis C; Non Hodgkin lymphoma; Telomerase; TERC gene

Indexed keywords

TELOMERASE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DOSAGE; GENETIC STABILITY; GENOME; HEPATITIS C; HUMAN; HUMAN TISSUE; LEUKOCYTE; NONHODGKIN LYMPHOMA; ONCOGENE; PRIORITY JOURNAL; TERC GENE; TUMOR GENE;

AGED; CHROMOSOMES, HUMAN, PAIR 3; GENE DOSAGE; HEPATITIS C; HUMANS; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; RNA; TELOMERASE;

EID: 77149140780     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900903095748     Document Type: Article

References (38)

1. Gajduskova, P.; Snijders, A.M.; Kwek, S.; Roydasgupta, R.; Fridlyand, J.; Tokuyasu, T.; Pinkel, D.; Albertson, D.G. Genome position and gene amplification. Genome Biol 2007, 8(6), R120.
2. Harley, C.B.; Futcher, A.B.; Greider, C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345(6274), 458-460.
3. Allsopp, R.C.; Vaziri, H.; Patterson, C.; Goldstein, S.; Younglai, E.V.; Futcher, A.B.; Greider, C.W.; Harley, C.B. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992, 89(21), 10114-10118.
4. Counter, C.M.; Avilion, A.A.; LeFeuvre, C.E.; Stewart, N.G.; Greider, C.W.; Harley, C.B.; Bacchetti, S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992, (5), 1921-1929.
5. Edington, K.G.; Loughran, O.P.; Berry, I.J.; Parkinson, E.K. Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss.Mol Carcinog 1995, 13(4), 254-265.
6. Kim, N.W.; Piatyszek,M.A.; Prowse, K.R.; Harley,C.B.;West, M.D.; Ho, P.L.; Coviello, G.M.; Wright, W.E.; Weinrich, S.L.; Shay, J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266(5193), 2011-2015.
7. Cao, Y.; Bryan, T.M.; Reddel, R.R. Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Sci 2008, 99(6), 1092-1099.
8. Bryce, L.A.; Morrison, N.; Hoare, S.F.; Muir, S.; Keith, W.N. Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization. Neoplasia 2000, 2(3), 197-201.
9. Soder, A.I.; Hoare, S.F.; Muire, S.; Balmain, A.; Parkinson, E.K.; Keith, W.N. Mapping of the gene for the mouse telomerase RNA component, Terc, to chromosome 3 by fluorescence in situ hybridization and mouse chromosome painting. Genomics 1997, 41(2), 293-294.
10. Monteverde, A.; Rivano, M.T.; Allegra, G.C.; Monteverde, A.I.; Zigrossi, P.; Baglioni, P.; Gobbi, M.; Falini, B.; Bordin, G.; Pileri, S. Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. Acta Haematol 1988, 79(1), 20-25.
11. Coleman, W.B. Mechanisms of human hepatocarcinogenesis. Curr Mol Med 2003, 3(6), 573-588.
12. Turner, N.C.; Dusheiko, G.; Jones, A. Hepatitis C and B-cell lymphoma. Ann Oncol 2003, 14(9), 1341-1345.
13. Satra, M.; Dalekos, G.N.; Kollia, P.; Vamvakopoulos, N.; Txezou, A. Telomerase reverse transcriptase mRNA expression in peripheral lymphocytes of patients with chronic HBV and HCV infections. J Viral Hepatitis 2005, 12, 488-493.
14. Armitage, J.O.; Weisenburger, D.D. New approach to classifying non-Hodgkin lymphoma: clinical features of the major histologic subtypes. J Clin Oncol 1998, 16, 2780-2795.
15. Gatter, K.C.;Warnke, R.A. Diffuse large B-cell lymphoma. InWorld Health Organization Classification of Tumors: Pathology and Genetics of Haematopoietic and Lymphoid Tissues, E.S. Jaffe, N.I. Harris, H. Stein, and J.W. Vardiman (eds.). Lyon, France, IARC Press, 2001, pp. 171-175.
16. Hunt, K.E.; Reichard, K.K. Diffuse large B-cell lymphoma. Arch Pathol Lab Med 2008, 132, 118-124.
17. Widmann, T.A.; Herrmann, M.; Taha, N.; Konig, J.; Pfreudschuh, M. Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis. Exp Hematol 2007, 35, 939-946.
18. Campbell, L.J. Cytogenetics of lymphomas. Pathology 2005, 6, 493-507.
19. Ventura, R.A. Centrosome abnormalities in ALK-positive anaplastic large-cell lymphoma. Leukemia 2004, 18, 1910-1911.
20. Amiel, A.; Elis, A.; Blumenthal, D.; Gaber, E.; Fejgin M.D.; Dubinsky, R., Lishner, M. Modified order of allelic replication in lymphoma patients at different disease stages. Cancer Genet Cytogenet 2001, 125, 156-160.
21. Goldberg-Bittman, L.; Kitay-Cohen, Y.; Hadary, R.; Yukla, M.; Fejgin, M.D.; Amiel, A. Random aneuploidy in chronic hepatitis C patients. Cancer Genet Cytogenet 2008, 108, 20-23.
22. Sugita, M.; Tanaka, N.; Davidson, S.; Sekiya, S.; Varella-Garcia, M.;West, J.; Drabkin, H.A.; Gemmill, R.M. Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung. Cancer Genet Cytogenet 2000, 117(1), 9-18.
23. Knuutila, S.; Bjorkqvist, A.M.; Autio, K.; Tarkkanen, M.; Wolf, M.; Monni, O.; Szymanska, J.; Larramendy, M.L.; Tapper, J.; Pere, H.; El-Rifai, W.; Hemmer, S.; Wasenius, V.M.; Vidgren, V.; Zhu, Y. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 1998, 152(5), 1107-1123. (Pubitemid 28221862)
24. Neiman, P.E.; Elsaesser, K.; Loring, G.; Kimmel, R. Myc oncogeneinduced genomic instability: DNA palindromes in bursal lymphomagenesis. PLoS Genet 2008, 4(7), e1000132.
25. Karube, K.; Ying, G.; Tagawa, H.; Niino, D.; Aoki, R.; Kimura, Y.; Hashikawa, K.; Suefuji, N.; Sugita, Y.; Nomura, Y.; Shimizu, K.; Yoshida, S.; Seto, M.; Ohshima, K. BCL6 gene amplification/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation. Mod Pathol 2008, 21(8), 973-978.
26. Young, K.H.; Xie, Q.; Zhou, G.; Eickhoff, J.C.; Sanger,W.G.; Aoun, P.; Chan, W.C. Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event. Am J Clin Pathol 2008, 129(1), 157-166.
27. Ely, S.A.; Chadburn, A.; Dayton, C.M.; Cesarman, E.; Knowles, D.M. Telomerase activity in B-cell non-Hodgkin lymphoma. Cancer 2000, 89(2), 445-452.
28. MacNamara, B.; Wang, W.; Chen, Z.; Hou, M.; Mazur, J.; Gruber, A.; Porwit-MacDonald, A. Telomerase activity in relation to pro- and anti-apoptotic protein expression in high grade non-Hodgkin's lymphomas. Haematologica 2001, 86(4), 386-393.
29. Onur, I.; Akman, S.; Olgun, A.; Fen, T.; Kutluay, T. Peripheral blood telomerase activity in non-Hodgkin lymphoma. Res Commun Mol Pathol Pharmacol 2003, 113-114, 298-306.
30. Klapper, W.; Krams, M.; Qian, W.; Janssen, D.; Parwaresch, R. Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation. Br J Cancer 2003, 89(4), 713-719.
31. Bodvarsd́ ottir, S.K.; Steinarsd́ ottir, M.; Hilmarsd́ ottir, H.; J́onasson, J.G.; Eyfjord, J.E. MYC amplification and TERT expression in breast tumor progression. Cancer Genet Cytogenet 2007, 176(2), 93-99.
32. Wu, K.J.; Grandori, C.; Amacker, M.; Simon-Vermot, N.; Polack, A.; Lingner, J.; Dalla-Favera, R. Direct activation of TERT transcription by c-MYC. Nat Genet 1999, 21(2), 220-224.
33. F.L. Greene, D.L. Page, I.D. Fleming, A.G. Fritz, C.M. Balch, D.G. Haller, and M. Morrow (eds). American Joint Committee on Cancer Staging Manual, 6th edition. Philadelphia, PA: Spinger, 2002.
34. Xu, D.; Wang, Q.; Gruber, A.; Bjorkholm, M.; Chen, Z.; Zaid, A.; Selivanova, G.; Peterson, C.; Wiman, K.G.; Pisa, P. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene 2000, 19(45), 5123-5133.
35. Goldberg-Bittman, L.; Kitay-Cohen, Y.; Quitt, M.; Hadary, R.; Fejgin, M.D.; Yukla, M.; Amiel, A. Telomere aggregates in non- Hodgkin lymphoma patients at different disease stages. Cancer Genet Cytogenet 2008, 184(2), 105-108.
36. Blasco, M.A. Telomerase beyond telomeres. Nat Rev Cancer 2002, 2(8), 627-633.
37. Amiel, A.; Fejgin, M.D.; Goldberg-Bittman, L.; Sharoni, R, Hadary R.; Kitay-Cohen, Y. Telomeres aggregates in hepatitis C patients. Cancer Investig 2009, 27(6), 650-654.
38. Kitay-Cohen, Y.; Goldberg-Bittman, L.; Hadary, R.; Fejgin, M.D.; Amiel, A. Telomere length in Hepatitis C. Cancer Genet Cytogenet 2008, 187(1), 34-38.